Home 2012

Archives

U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)

On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate because of...

Perfecting your acid-base balancing act

Don’t miss the opportunity to practice your arterial blood gas interpretation skills.

FDA recommends more conservative dosing guidelines for erythropoiesis-stimulating agents

The U.S. Food and Drug Administration (FDA) is recommending more conservative dosing guidelines for erythropoiesis-stimulating agents (ESAs) when they are used to treat anemia...

FDA approves Nulojix for prevention of acute rejection in kidney transplant patients

The U.S. Food and Drug Administration (FDA) has approved Nulojix (belatacept) for prevention of acute rejection in adult patients who have had a kidney...

Reversing opioid-induced respiratory depression

For a patient receiving high-dose opioids, frequent monitoring of the sedation level and quick intervention when that level increases stops respiratory depression from claiming another victim.
nephrology kidney specialty

Nephrology nurses: Passionate about their specialty

“What I find most exciting and interesting about the specialty is that we are truly dealing with every organ system,” says Anne Harty, MS,...

CRRT spells success against acute renal failure in critically ill patients

Why critically ill patients with acute renal failure need continuous renal replacement therapy.

Discovering and stopping hyperkalemia

Fast, focused assessment and action can stop this dangerous imbalance.

Sickle cell trait can take a sudden deadly turn

For someone with sickle cell trait, exercise can trigger dangerous complications.  But most people who have the trait, don't know it.

Microalbumin: Little test, big payoff

The earlier renal disease is detected, the better. That's why the microalbumin test is so important for patients with certain chronic conditions.